Clicky

Convatec Group Plc(CTEC)

Description: ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. It operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets. Its products include FlexiSeal Signal, FlexiSeal Fecal Collector and Intermittent Catheters.


Keywords: Medicine Cancer Disease Diabetes Skin Care Medical Equipment Skin Care Products Catheter Multiple Sclerosis Colorectal Cancer Obesity Franchises Skin Inflammatory Bowel Disease Gastroenterology Bladder Cancer Stoma Urinary Incontinence Treatment Of Diabetes Continence Spinal Cord Injuries Therapies Convatec Infusion Devices Spina Bifida

Home Page: www.convatecgroup.com

CTEC Technical Analysis

3 Forbury Place
Reading, RG1 3JH
United Kingdom
Phone: 44 11 8952 8100


Officers

Name Title
Mr. Karim Bitar CEO & Director
Mr. Jonathan P. Mason Group CFO & Director
Mr. Donal Balfe Exec. VP and Chief of Quality & Operations
Dr. Divakar Ramakrishnan Ph.D. Exec. VP & Chief Technology Officer
Mr. Mark Reynolds Director of Investor Relations
Ms. Kate Postans VP of Investor Relations & Corp. Communications
Ms. Natalia Kozmina Exec. VP & Chief HR Officer
Mr. Christian Hoengaard Sr. VP & GM - USA
Ms. Kjersti Grimsrud Biotechnology, M.Sc. Pres & COO of Infusion Care
Mr. Supratim Bose Pres & COO of Global Emerging Markets

Exchange: LSE

Country: UK

Currency: Pence sterling (p)

Forward PE: 21.4133
Trailing PE: 82.4
Price-to-Book MRQ: 3.7498
Price-to-Sales TTM: 2.2381
IPO Date:
Fiscal Year End: December
Full Time Employees: 10000
Back to stocks